Skip to main content

The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro


The present study aimed to determine the in vitro biological efficacy and selectivity of 7 novel AIAs upon bloodstream trypomastigotes and intracellular amastigotes of Trypanosoma cruzi. The biological activity of these aromatic compounds was assayed for 48 and 24 h against intracellular parasites and bloodstream forms of T. cruzi (Y strain), respectively. Additional assays were also performed to determine their potential use in blood banks by treating the bloodstream parasites with the compounds diluted in mouse blood for 24 h at 4°C. Toxicity against mammalian cells was evaluated using primary cultures of cardiac cells incubated for 24 and 48 h with the AIAs and then cellular death rates were determined by MTT colorimetric assays. Our data demonstrated the outstanding trypanocidal effect of AIAs against T. cruzi, especially DB1853, DB1862, DB1867 and DB1868, giving IC50 values ranging between 16 and 70 nanomolar against both parasite forms. All AIAs presented superior efficacy to benznidazole and some, such as DB1868, also demonstrated promising activity as a candidate agent for blood prophylaxis. The excellent anti-trypanosomal efficacy of these novel AIAs against T. cruzi stimulates further in vivo studies and justifies the screening of new analogues with the goal of establishing a useful alternative therapy for Chagas disease.

Corresponding author
*Corresponding author: Laboratório de Biologia Celular, Maria de Nazaré Correia Soeiro, Av. Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, Brazil. Tel: +055 21 25621368. Fax: +055 21 2562-1432. E-mail:
Hide All
Apted F. I. (1980). Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the Eastern Hemisphere. Pharmacology & Therapeutics 11, 391413.
Bailly C., Dassonneville L., Carrasco C., Lucas D., Kumar A., Boykin D. W. and Wilson W. D. (1999). Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives. Anti-Cancer Drug Design 14, 4760.
Batista D. da G., Batista M. M., de Oliveira G. M., do Amaral P. B., Lannes-Vieira J., Britto C. C., Junqueira A., Lima M. M., Romanha A. J., Sales Junior P. A., Stephens C. E., Boykin D. W. and Soeiro N. (2010). Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment. Antimicrobial Agents and Chemotherapy 54, 29402952.
Bell C. A., Cory M., Fairley T. A., Hall J. E. and Tidwell R. R. (1991). Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity. Antimicrobial Agents and Chemotherapy 35,1099–107.
Bettiol E., Samanovic M., Murkin A. S., Raper J., Buckner F. and Rodriguez A. (2009). Identification of three classes of heteroaromatic compounds with activity against intracellular Trypanosoma cruzi by chemical library screening. PLoS Neglected Tropical Diseases 3, e384.
Bryceson A. D., Chulay J. D., Mugambi M., Were J. B., Gachihi G., Chunge C. N., Muigai R., Bhatt S. M., Ho M., Spencer H. C., Meme J. and Anabwani G. (1985). Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine. Transactions of the Royal Society of Tropical Medicine and Hygiene 79, 705714.
Caldas I. S., Talvani A., Caldas S., Carneiro C. M., de Lana M., da Matta Guedes P. M. and Bahia M. T. (2008). Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions. Parasitology Research 103, 413–21.
Clayton J. (2010). Chagas disease: pushing through the pipeline. Nature, London S12S15.
Coura J. R. and Viñas P. A. (2010). Chagas disease: a new worldwide challenge. Nature Outlooks 465 (7301 suppl), S6S7.
da Silva C. F., Batista M. M., Batista D.da G., de Souza E. M., da Silva P. B., de Oliveira G. M., Meuser A. S., Shareef A. R., Boykin D. W. and Soeiro M. de N. (2008). In vitro and in vivo studies of the trypanocidal activity of a diarylthiophene diamidine against Trypanosoma cruzi. Antimicrobial Agents and Chemotherapy 52, 33073314.
da Silva C. F., da Silva P. B., Batista M. M., Daliry A., Tidwell R. R. and Soeiro M. de N. (2010). The biological in vitro effect and selectivity of aromatic dicationic compounds on Trypanosoma cruzi. Memorias do Instituto Oswaldo Cruz 105, 239245.
Daliry A., Da Silva P. B., Da Silva C. F., Batista M. M., De Castro S. L., Tidwell R. R. and Soeiro M. de N. (2009). In vitro analyses of the effect of aromatic diamidines upon Trypanosoma cruzi. Jounal of Antimicrobial Chemotherapy 64, 747750.
de Koning H. P. (2001). Transporters in African trypanosomes: role in drug action and resistance. International Journal for Parasitology 31, 512522.
De Souza E. M., da Silva P. B., Nefertiti A. S., Ismail M. A., Arafa R. K., Tao B., Nixon-Smith C. K., Boykin D. W. and Soeiro M. N. (2011). Trypanocidal activity and selectivity in vitro of aromatic amidine compounds upon bloodstream and intracellular forms of Trypanosoma cruzi. Experimental Parasitology 127, 429435.
De Souza E. M., Lansiaux A., Bailly C., Wilson W. D., Hu Q., Boykin D. W., Batista M. M., Araújo-Jorge T. C. and Soeiro M. N. (2004). Phenyl substitution of furamidine markedly potentiates its antiparasitic activity against Trypanosoma cruzi and Leishmania amazonensis. Biochemical Pharmacology 68, 593600.
De Souza E. M., Nefertiti A. S., Bailly C., Lansiaux A. and Soeiro M. N. (2010). Differential apoptosis-like cell death in amastigote and trypomastigote forms from Trypanosoma cruzi-infected heart cells in vitro. Cell and Tissue Research 341, 173180.
De Souza E. M., Oliveira G. M., Boykin D. W., Kumar A., Hu Q. and Soeiro M. N. C. (2006). Trypanocidal activity of the phenyl-substituted analogue of furamidine DB569 against Trypanosoma cruzi infection in vivo. Journal of Antimicrobial Chemotherapy 58, 610614.
Farahat A. A., Paliakov E., Kumar A., Barghash A. E., Goda F. E., Eisa H. M., Wenzler T., Brun R., Liu Y., Wilson W. D. and Boykin D. W. (2011). Exploration of larger central ring linkers in furamidine analogues: Synthesis and evaluation of their DNA binding, antiparasitic and fluorescence properties. Bioorganic & Medicinal Chemistry 19, 21562167.
Francesconi I., Wilson W. D., Tanious F. A., Hall J. E., Bender B. C., Tidwell R. R., McCurdy D. and Boykin D. W. (1999). 2,4-Diphenyl furan diamidines as novel anti-Pneumocystis carinii pneumonia agents. Journal of Medicinal Chemistry 42, 22602265.
Hu L., Arafa R. K., Ismail M. A., Patel A., Munde M., Wilson W. D., Wenzler T., Brun R. and Boykin D. W. (2009). Synthesis and activity of azaterphenyl diamidines against Trypanosoma brucei rhodesiense and Plasmodium falciparum. Bioorganic & Medicinal Chemistry 17, 66516658.
Kim S. Y., Dabb A. A., Glenn D. J., Snyder K. M., Chuk M. K. and Loeb D. M. (2008). Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients. Pediatric Blood & Cancer 50, 779783.
Lanteri C. A., Stewart M. L., Brock J. M., Alibu V. P., Meshnick S. R., Tidwell R. R. and Barrett M. P. (2006). Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance. Molecular Pharmacology 70,15851592.
Laranja F. S., Dias E. and Nobrega G. (1951). Clinical aspect and treatment of Chagas' disease. Prensa Medicine Argentina 38, 465484.
Lindsay D. S., Blagburn B. L., Hall J. E. and Tidwell R. R. (1991). Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures. Antimicrobial Agents and Chemotherapy 35,19141916.
Machado F. S., Tanowitz H. B. and Teixeira M. M. (2010). New drugs for neglected infectious diseases: Chagas' disease. British Journal of Pharmacology 160, 258259.
Mathis A. M., Holman J. L., Sturk L. M., Ismail M. A., Boykin D. W., Tidwell R. R. and Hall J. E. (2006). Accumulation and intracellular distribution of antitrypanosomal diamidine compounds DB75 and DB820 in African trypanosomes. Antimicrobial Agents and Chemotherapy 50, 21852191.
Mathis A. M., Bridges A. S., Ismail M. A., Kumar A., Francesconi I., Anbazhagan M., Hu Q., Tanious F. A., Wenzler T., Saulter J., Wilson W. D., Brun R., Boykin D. W., Tidwell R. R. and Hall J. E. (2007). Diphenyl furans and aza analogs: effects of structural modification on in vitro activity, DNA binding, and accumulation and distribution in trypanosomes. Antimicrobial Agents and Chemotherapy 51, 28012810.
Mazur S., Tanious F. A., Ding D., Kumar A., Boykin D. W., Simpson I. J., Neidle S. and Wilson W. D. (2000). A thermodynamic and structural analysis of DNA minor-groove complex formation. Journal of Molecular Biology 300, 321337.
Meirelles M. N., Araujo-Jorge T. C., Miranda C. F., De Souza W. and Barbosa H. S. (1986). Interaction of Trypanosoma cruzi with heart muscle cells: ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro. European Journal of Cell Biology 41, 198206.
Pacheco M. G., da Silva C. F., de Souza E. M., Batista M. M., da Silva P. B., Kumar A., Stephens C. E., Boykin D. W. and Soeiro M. de N. (2009). Trypanosoma cruzi: activity of heterocyclic cationic molecules in vitro. Experimental Parasitology 123, 7380.
Purfield A. E., Tidwell R. R. and Meshnick S. R. (2009). The diamidine DB75 targets the nucleus of Plasmodium falciparum. Malaria Journal 8, 19.
Rassi A. Jr., Rassi A. and Marin-Neto J. A. (2010). Chagas disease. Lancet 375, 13881402.
Rocha M. O., Teixeira M. M. and Ribeiro A. L. (2007). An update on the management of Chagas cardiomyopathy. Expert Review of Anti-Infective Therapy 5, 727743.
Rodriques Coura J. and de Castro S. L. (2002). A critical review on Chagas disease chemotherapy. Memórias do Instituto Oswaldo Cruz 97, 324.
Rosypal A. C., Tidwell R. R. and Lindsay D. S. (2007). Prevalence of antibodies to Leishmania infantum and Trypanosoma cruzi in wild canids from South Carolina. Journal of Parasitology 93, 955957.
Rosypal A. C., Werbovetz K. A., Salem M., Stephens C. E., Kumar A., Hall J. E. and Tidwell R. R. (2008). Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis. Journal of Parasitology 94, 743749.
Silva C. F., Batista M. M., Mota R. A., de Souza E. M., Stephens C. E., Som P., Boykin D. W. and Soeiro M. de N. (2007 a). Activity of “reversed” diamidines against Trypanosoma cruzi “in vitro. Biochemical Pharmacology 73, 19391946.
Silva C. F., Meuser M. B., De Souza E. M., Meirelles M. N., Stephens C. E., Som P., Boykin D. W. and Soeiro M. N. (2007 b). Cellular effects of reversed amidines on Trypanosoma cruzi. Antimicrobial Agents and Chemotherapy 51, 38033809.
Soeiro M. N. and de Castro S. L. (2009). Trypanosoma cruzi targets for new chemotherapeutic approaches. Expert Opinion Therapy Targets 13, 105121.
Soeiro M. De N. and de Castro S. L. (2011). Screening of potential anti-Trypanosoma cruzi candidates: in vitro and in vivo studies. Open Medicinal Chemistry Journal 5, 2130.
Soeiro M. N. C., Daliry A., Silva C. F., Batista D. G. J., de Souza E. M., Oliveira G. M., Salomão K., Menna-Barreto R. F. S. and de Castro S. L. (2010). Electron microscopy approaches for the investigation of the cellular targets of trypanocidal agents in Trypanosoma cruzi In Microscopy: Science, Technology, Applications and Education 1, 191203. Formatex Research Center, Badajoz, Spain.
Soeiro M. de N., Dantas A. P., Daliry A., Silva C. F., Batista D. G., de Souza E. M., Oliveira G. M., Salomão K., Batista M. M., Pacheco M. G., Silva P. B., Santa-Rita R. M., Barreto R. F., Boykin D. W. and Castro S. L. (2009). Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies. Memórias do Instituto Oswaldo Cruz 104, 301310.
Soeiro M. N., De Souza E. M., Stephens C. E. and Boykin D. W. (2005). Aromatic diamidines as antiparasitic agents. Expert Opinion on Investigational Drugs 14, 957972.
Stephens C. E., Brun R., Salem M. M., Werbovetz K. A., Tanious F., Wilson W. D. and Boykin D. W. (2003). The activity of diguanidino and “reversed” diamidino 2,5-diarylfurans versus Trypanosoma cruzi and Leishmania donovani. Bioorganic & Medicinal Chemistry Letters 13, 20652069.
Wang L., Bailly C., Kumar A., Ding D., Bajic M., Boykin D. W. and Wilson W. D. (2000). Specific molecular recognition of mixed nucleic acid sequences: an aromatic dication that binds in the DNA minor groove as a dimer. Proceedings of the National Academy of Sciences, USA 97, 1216.
Wang M. Z., Zhu X., Srivastava A., Liu Q., Sweat J. M., Pandharkar T., Stephens C. E., Riccio E., Parman T., Munde M., Mandal S., Madhubala R., Tidwell R. R., Wilson W. D., Boykin D. W., Hall J. E., Kyle D. E. and Werbovetz K. A. (2010). Novel arylimidamides for treatment of visceral leishmaniasis. Antimicrobial Agents and Chemotherapy 54, 25072516.
Wenzler T., Boykin D. W., Ismail M. A., Hall J. E., Tidwell R. R. and Brun R. (2009). New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289. Antimicrobial Agents and Chemotherapy 53, 41854192.
Werbovetz K. (2006). Diamidines as antitrypanosomal, antileishmanial and antimalarial agents. Current Opinion in Investigational Drugs 7, 147157.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

  • ISSN: 0031-1820
  • EISSN: 1469-8161
  • URL: /core/journals/parasitology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 4
Total number of PDF views: 17 *
Loading metrics...

Abstract views

Total abstract views: 133 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th November 2017. This data will be updated every 24 hours.